These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 15586226

  • 1. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC, Lin JK, Lin TC, Liang WY.
    Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
    [Abstract] [Full Text] [Related]

  • 2. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
    Wu CM, Tang R, Chen JR, Wu MC, Chien HT, Changchien CR, Hsieh LL.
    Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
    [Abstract] [Full Text] [Related]

  • 3. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ, Feigl P, Quan G, Fenoglio-Preiser C, Lovato LC, Bunn PA, Stemmerman G, Wells JD, Macdonald JS, Meyskens FL.
    Cancer Res; 1998 Mar 15; 58(6):1149-58. PubMed ID: 9515799
    [Abstract] [Full Text] [Related]

  • 4. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A, Kressner U, Lönnroth C, Andersson M, Lindmark G, Lundholm K.
    Int J Oncol; 2002 Aug 15; 21(2):409-15. PubMed ID: 12118339
    [Abstract] [Full Text] [Related]

  • 5. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, Huang YS, Huang CJ, Wang JY.
    Am Surg; 2005 Apr 15; 71(4):336-43. PubMed ID: 15943410
    [Abstract] [Full Text] [Related]

  • 6. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
    Russo A, Migliavacca M, Zanna I, Valerio MR, Latteri MA, Grassi N, Pantuso G, Salerno S, Dardanoni G, Albanese I, La Farina M, Tomasino RM, Gebbia N, Bazan V.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 15; 11(11):1322-31. PubMed ID: 12433709
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M, Ataizi-Celikel C, Düşünceli F, Sönmez O, Gulluoglu BM, Sav A, Ozer A.
    J Gastrointestin Liver Dis; 2007 Mar 15; 16(1):11-7. PubMed ID: 17410283
    [Abstract] [Full Text] [Related]

  • 8. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI.
    Anticancer Res; 2001 Mar 15; 21(1A):253-9. PubMed ID: 11299743
    [Abstract] [Full Text] [Related]

  • 9. Expression of high p53 levels in colorectal cancer: a favourable prognostic factor.
    Adrover E, Maestro ML, Sanz-Casla MT, del Barco V, Cerdán J, Fernández C, Balibrea JL.
    Br J Cancer; 1999 Sep 15; 81(1):122-6. PubMed ID: 10487622
    [Abstract] [Full Text] [Related]

  • 10. Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection.
    Molleví DG, Serrano T, Ginestà MM, Valls J, Torras J, Navarro M, Ramos E, Germà JR, Jaurrieta E, Moreno V, Figueras J, Capellà G, Villanueva A.
    Carcinogenesis; 2007 Jun 15; 28(6):1241-6. PubMed ID: 17259658
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
    Liang JT, Chang KJ, Chen JC, Lee CC, Cheng YM, Hsu HC, Chien CT, Wang SM.
    Hepatogastroenterology; 1999 Jun 15; 46(26):883-90. PubMed ID: 10370632
    [Abstract] [Full Text] [Related]

  • 12. The role of combined allelic imbalance and mutations of p53 in tumor progression and survival following surgery for colorectal carcinoma.
    Lagerstedt KK, Kressner U, Lönnroth C, Nordgren S, Lundholm K.
    Int J Oncol; 2005 Dec 15; 27(6):1707-15. PubMed ID: 16273227
    [Abstract] [Full Text] [Related]

  • 13. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE, Karafoka E, Papailiou JG, Stamopoulos P, Zambirinis CP, Bramis K, Panoussopoulos SG, Leandros E, Bramis J.
    Anticancer Res; 2009 Feb 15; 29(2):785-91. PubMed ID: 19331236
    [Abstract] [Full Text] [Related]

  • 14. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
    Soong R, Grieu F, Robbins P, Dix B, Chen D, Parsons R, House A, Iacopetta B.
    Clin Cancer Res; 1997 Aug 15; 3(8):1405-11. PubMed ID: 9815825
    [Abstract] [Full Text] [Related]

  • 15. p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma.
    Kahlenberg MS, Stoler DL, Rodriguez-Bigas MA, Weber TK, Driscoll DL, Anderson GR, Petrelli NJ.
    Cancer; 2000 Apr 15; 88(8):1814-9. PubMed ID: 10760757
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. RER and LOH association with sporadic colorectal cancer in Taiwanese patients.
    Tsai MH, Yang YC, Chen KH, Jiang JK, Chou SJ, Chiang TC, Jan HS, Lou MA.
    Hepatogastroenterology; 2002 Apr 15; 49(45):672-7. PubMed ID: 12063967
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M, Gerstlauer C, Grimm M, Bueter M, Lebedeva T, Lutz J, Maeder U, Ribas C, Ribas C, Nichiporuk E, Thalheimer A, Heemann U, Thiede A, Meyer D, Waaga-Gasser AM.
    Ann Surg Oncol; 2007 Apr 15; 14(4):1272-84. PubMed ID: 17211733
    [Abstract] [Full Text] [Related]

  • 20. Evolution of intratumoral genetic heterogeneity during colorectal cancer progression.
    Losi L, Baisse B, Bouzourene H, Benhattar J.
    Carcinogenesis; 2005 May 15; 26(5):916-22. PubMed ID: 15731168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.